medigraphic.com
SPANISH

Revista Médica Sinergia

Revista Médica Sinergia
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2019, Number 06

<< Back

Revista Médica Sinergia 2019; 4 (06)

Testicular yolk sac (endodermal sinus) tumor in the pediatric age

Segura GJM, Peña MM, Molina JVN
Full text How to cite this article

Language: Spanish
References: 17
Page: 108-119
PDF size: 487.68 Kb.


Key words:

endodermal sinus tumor, neoplasms, germ cell and embryonal, alpha fetus protein, cryptorchidism.

ABSTRACT

Yolk sac tumors (YST) represent the most frequent malignant testicular germ cell tumors (GCT) in the pediatric age. This neoplasm, like the other subtypes of GCT, have been linked to risk factors such as cryptorchidism, family history of testicular neoplasia or GCT, genetic alterations and testicular microlithiasis. The age of presentation in most cases is around 16 and 17 months of age. In general, they present as asymptomatic testicular masses, so that parents or primary care physicians are usually the first to identify them. YST characteristically produce alpha fetoprotein (AFP), so this is considered the most important serological marker for diagnosis and follow-up after treatment. Scrotal ultrasound is considered the most important diagnostic tool for the characterization of testicular masses. It is said that in general the yolk sac tumors present as solid masses, with great hypervascularity. The majority of patients present initially with stage I disease, with radical orchiectomy being the only therapy required in this phase. In more advanced cases, the implementation of platinumbased chemotherapy has been shown to improve survival.


REFERENCES

  1. Wei Y, Wu S, Lin T, He D, Li X, et al. Testicular yolk sac tumors in children: a review of 61 patients over 19 years. World Journal of Surgical Oncology. 2014; 12(1): 400.https://doi.org/10.1186/1477-7819-12-400

  2. Rescorla F. The Surgery of Childhood Tumors. 1st Ed. Berlin: Springer; c2016. Malignant Germ Cell Tumors; p. 333-344. https://doi.org/10.1007/978-3-662-48590-3_19

  3. Cecchetto G. Gonadal germ cell tumors in children and adolescents. Journal of Indian Association of Pediatric Surgeons. 2014; 19(4): 189-194. https://doi.org/10.4103/0971-9261.141995

  4. Cornejo K, Frazier L, Lee R, et al. Yolk Sac Tumor of the Testis in Infants and Children. The Ameri-can Journal of Surgical Pathology. 2015; 39(8): 1121-1131.https://doi.org/10.1097/PAS.0000000000000432

  5. Wein A, Kavoussi L, Novick A, et al. Campbell-Walsh Urología. 10th ed. México, D.F.: Médica Panamericana; c2015. Capítulo 137, Oncología urológica pediátrica; p. 3717-3750.

  6. Hanna N, Einhorn L. Testicular Cancer - Discoveries and Updates. New England Journal of Medi-cine. 2014; 371(21): 2005-2016. https://doi.org/10.1056/NEJMra1407550

  7. Kolon T, Herndon C, Beker L, et al. Evaluation and Treatment of Cryptorchidism: AUA Guideline. The Journal of Urology. 2014; 192(2): 337-345.https://doi.org/10.1016/j.juro.2014.05.005

  8. Braga L, Lorenzo A, Romao R. Canadian Urological Association-Pediatric Urologists of Canada (CUAPUC) guideline for the diagnosis, management, and followup of cryptorchidism. Canadian Urological Association Journal. 2017; 11(7): E251-E260.https://doi.org/10.5489/cuaj.4585

  9. Poynter J, Richardson M. Family history of cancer in children and adolescents with germ cell tu-mours: a report from the Children’s Oncology Group. British Journal of Cancer. 2017; 118(1): 121- 126. https://doi.org/10.1038/bjc.2017.358

  10. Trout A, Chow J, McNamara E, et al. Association between Testicular Microlithiasis and Testicular Neoplasia: Large Multicenter Study in a Pediatric Population. Radiology. 2017; 285(2): 576- 583. https://doi.org/10.1148/radiol.2017162625

  11. Suominen J, Jawaid W, Losty P. Testicular microlithiasis and associated testicular malignancies in childhood: A systematic review. Pediatric Blood & Cancer. 2014; 62(3): 385-388. https://doi.org/10.1002/pbc.25343

  12. Song Q. Ultrasound Appearances of Pediatric Testicular Yolk Sac Tumors: Twenty-one Cases in a Single Institution. Journal of Ultrasound in Medicine. 2018; 37(10): 2457-2463.https://doi.org/10.1002/jum.14597

  13. Grantham E, Caldwell B, Cost N. Current urologic care for testicular germ cell tumors in pediatric and adolescent patients. Urologic Oncology: Seminars and Original Investigations. 2016 02;34(2):65- 75. https://doi.org/10.1016/j.urolonc.2015.06.008

  14. Tasian G, Kolon T. Fundamentals of Pediatric Surgery. 1st Ed. Cham: Springer; c2017. Testicular Tumors: p. 819-823. https://doi.org/10.1007/978-3-319-27443-0_103

  15. Woo L, Ross J. The role of testis-sparing surgery in children and adolescents with testicular tumors. Urologic Oncology: Seminars and Original Investigations. 2016 02; 34(2): 76- 83.https://doi.org/10.1016/j.urolonc.2015.05.019

  16. Long C, Ginsberg J, Kolon T. Fertility Preservation in Children and Adolescents With Cancer. Urol-ogy. 2016; 91: 190-196. https://doi.org/10.1016/j.urology.2015.10.047

  17. Rescorla F, Ross J, Billmire F, et al. Surveillance after initial surgery for Stage I pediatric and adolescent boys with malignant testicular germ cell tumors: Report from the Children’s Oncology Group. Journal of Pediatric Surgery. 2015; 50(6): 1000-1003.https://doi.org/10.1016/j.jpedsurg.2015.03.026




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Revista Médica Sinergia. 2019;4